These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 25388260)

  • 1. Induction of mast cell apoptosis by a novel secretory granule-mediated pathway.
    Melo FR; Wernersson S; Pejler G
    Methods Mol Biol; 2015; 1220():325-37. PubMed ID: 25388260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell apoptosis induced by siramesine, a sigma-2 receptor agonist.
    Spirkoski J; Melo FR; Grujic M; Calounova G; Lundequist A; Wernersson S; Pejler G
    Biochem Pharmacol; 2012 Dec; 84(12):1671-80. PubMed ID: 23058984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway.
    Melo FR; Waern I; Rönnberg E; Åbrink M; Lee DM; Schlenner SM; Feyerabend TB; Rodewald HR; Turk B; Wernersson S; Pejler G
    J Biol Chem; 2011 Feb; 286(7):5423-33. PubMed ID: 21123167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal membrane permeabilization induces cell death in human mast cells.
    Melo FR; Lundequist A; Calounova G; Wernersson S; Pejler G
    Scand J Immunol; 2011 Oct; 74(4):354-62. PubMed ID: 21645032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic histone modification by mast cell tryptase, a serglycin proteoglycan-dependent secretory granule protease.
    Melo FR; Vita F; Berent-Maoz B; Levi-Schaffer F; Zabucchi G; Pejler G
    J Biol Chem; 2014 Mar; 289(11):7682-90. PubMed ID: 24478313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells limit extracellular levels of IL-13 via a serglycin proteoglycan-serine protease axis.
    Waern I; Karlsson I; Thorpe M; Schlenner SM; Feyerabend TB; Rodewald HR; Åbrink M; Hellman L; Pejler G; Wernersson S
    Biol Chem; 2012 Dec; 393(12):1555-67. PubMed ID: 23667909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components.
    Henningsson F; Hergeth S; Cortelius R; Abrink M; Pejler G
    FEBS J; 2006 Nov; 273(21):4901-12. PubMed ID: 17010166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity.
    Stevens RL; Adachi R
    Immunol Rev; 2007 Jun; 217():155-67. PubMed ID: 17498058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serglycin proteoglycan promotes apoptotic versus necrotic cell death in mast cells.
    Melo FR; Grujic M; Spirkoski J; Calounova G; Pejler G
    J Biol Chem; 2012 May; 287(22):18142-52. PubMed ID: 22493512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction with dithiothreitol causes serglycin-specific defects in secretory granule integrity of bone marrow derived mast cells.
    Braga T; Ringvall M; Tveit H; Abrink M; Pejler G
    Mol Immunol; 2009 Jan; 46(3):422-8. PubMed ID: 19059647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells.
    Braga T; Grujic M; Lukinius A; Hellman L; Abrink M; Pejler G
    Biochem J; 2007 Apr; 403(1):49-57. PubMed ID: 17147513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mefloquine, an anti-malaria agent, causes reactive oxygen species-dependent cell death in mast cells via a secretory granule-mediated pathway.
    Paivandy A; Calounova G; Zarnegar B; Ohrvik H; Melo FR; Pejler G
    Pharmacol Res Perspect; 2014 Dec; 2(6):e00066. PubMed ID: 25505612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-Activated Protein Kinase Signaling Regulates Proteoglycan Composition of Mast Cell Secretory Granules.
    Hu Frisk JM; Kjellén L; Melo FR; Öhrvik H; Pejler G
    Front Immunol; 2018; 9():1670. PubMed ID: 30073001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway.
    Lampinen M; Hagforsen E; Weström S; Bergström A; Levedahl KH; Paivandy A; Lara-Valencia P; Pejler G; Rollman O
    Exp Dermatol; 2022 Nov; 31(11):1729-1740. PubMed ID: 35876458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distorted secretory granule composition in mast cells with multiple protease deficiency.
    Grujic M; Calounova G; Eriksson I; Feyerabend T; Rodewald HR; Tchougounova E; Kjellén L; Pejler G
    J Immunol; 2013 Oct; 191(7):3931-8. PubMed ID: 23975861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mast cells arise from a common circulating progenitor.
    Maaninka K; Lappalainen J; Kovanen PT
    J Allergy Clin Immunol; 2013 Aug; 132(2):463-9.e3. PubMed ID: 23582567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serglycin: the master of the mast cell.
    Rönnberg E; Pejler G
    Methods Mol Biol; 2012; 836():201-17. PubMed ID: 22252637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell-dependent activation of pro matrix metalloprotease 2: A role for serglycin proteoglycan-dependent mast cell proteases.
    Lundequist A; Abrink M; Pejler G
    Biol Chem; 2006; 387(10-11):1513-9. PubMed ID: 17081126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 and IL-17A degradation by mast cells is mediated by a serglycin:serine protease axis.
    Waern I; Karlsson I; Pejler G; Wernersson S
    Immun Inflamm Dis; 2016 Mar; 4(1):70-9. PubMed ID: 27042303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mast cell: an evolutionary perspective.
    Crivellato E; Ribatti D
    Biol Rev Camb Philos Soc; 2010 May; 85(2):347-60. PubMed ID: 19961471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.